Active Pharmaceutical Ingredients (APIs)

  • Palbociclib*

    • API Product   :   

      Palbociclib*

    • CEP   :   

      -

    • WCC   :   

      -

    • Therapeutic Use    :   

      Antineoplastics

    • Originator   :   

      PFIZER

    • CAS No.    :   

      571190-30-2

    • Trade Name.   :   

      IBRANCE

    • Molecular Weight   :   

      447.533 g/mol

    • Molecular Formula   :   

      C24H29N7O2

    Application

    Palbociclib is used to treat a certain type of breast cancer in women. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

    General Description

    Palbociclib (codenamed PD-0332991, trade name Ibrance) is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.[1][2] Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy by any organization.